PA
TSHA icon

Parallel Advisors’s Taysha Gene Therapies TSHA Stock Holding History

Parallel Advisors’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.28K Buy
286
+6
+2% +$28 ﹤0.01% 3490
2025
Q4 		$1.54K Hold
280
– – ﹤0.01% 3204
2025
Q3 		$916 Hold
280
– – ﹤0.01% 3241
2025
Q2 		$647 Hold
280
– – ﹤0.01% 3271
2025
Q1 		$389 Hold
280
– – ﹤0.01% 3277
2024
Q4 		$484 Hold
280
– – ﹤0.01% 3228
2024
Q3 		$563 Hold
280
– – ﹤0.01% 3163
2024
Q2 		$627 Buy
+280
New +$815 ﹤0.01% 3051
2022
Q1 		– Sell
-45
Closed -$1K – 3277
2021
Q4 		$1K Buy
+45
New +$679 ﹤0.01% 2971

Other funds holding TSHA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM